• 3,000 firms
  • Independent
  • Trusted
Save up to 70% on staff

News » Healthcare BPO firm GeBBS eyes $1Bn valuation in sale

Healthcare BPO firm GeBBS eyes $1Bn valuation in sale

NEW DELHI, INDIA — Investment firm ChrysCapital is reportedly exploring the sale of its portfolio company GeBBS Healthcare Solutions, at a valuation of around $1 billion.

ChrysCapital had acquired an 80% stake in GeBBS in 2018 for $140 million, valuing the company at $175 million at that time. 

ChrysCapital to make lucrative profits off GeBBS sale

The potential $1 billion sale would mark a significant profit for the investment firm on its investment just four years ago.

A report by The Economic Times revealed that ChrysCapital has been talking to investment banks to gauge interest from potential buyers, including other private equity funds and key players in the healthcare revenue cycle management (RCM) space. 

ChrysCapital has tapped U.S. investment bank and capital markets firm Jefferies to run the sale process to global funds.

Performance of GeBBS under ChrysCapital

GeBBS has grown rapidly under ChrysCapital through a combination of organic growth and strategic acquisitions. 

In 2023, Modern Healthcare ranked it among the top 20 largest RCM firms, and it has won other accolades for its medical coding and billing solutions. 

Founded in 2005, GeBBS offers RCM solutions and is regarded as one of the leaders in the Health Information Management (HIM), RCM, patient contact, risk adjustment, and quality segment. It employs over 14,000 workers globally.

Wipro, IBM, Cognizant, and Hewlett-Packard are some of GeBBS’ competitors.

ChrysCapital has been an active investor in the IT/ITeS sector, generating lucrative returns from its investments in companies like Infosys, HCL Technologies, Mphasis, and Hexaware Technologies.

In 2013, the firm sold its stake in Hexaware to Baring Private Equity Asia (now EQT), realizing a threefold return. 

In 2017, ChrysCapital pulled its investment in Hyderabad-based Cyient with a fivefold return and also divested its entire 13.5% stake in IT consultancy firm KPIT Technologies during the same year.

ChrysCapital’s recent exit from Mankind Pharma yielded an internal rate of return (IRR) of 24%. With a total investment of ₹2,210 crore ($264,344.95) in Mankind Pharma, the firm made an exit worth ₹7,510 crore ($898,294.38).

Read more here.

Start your
journey today

  • Independent
  • Free
  • Transparent

About OA

Outsource Accelerator is the trusted source of independent information, advisory and expert implementation of Business Process Outsourcing (BPO)

The #1 outsourcing authority

Outsource Accelerator offers the world’s leading aggregator marketplace for outsourcing. It specifically provides the conduit between Philippines outsourcing suppliers and the businesses – clients – across the globe.

The Outsource Accelerator website has over 5,000 articles, 350+ podcast episodes, and a comprehensive directory with 900+ BPO companies… all designed to make it easier for clients to learn about – and engage with – outsourcing.

About Derek Gallimore

Derek Gallimore has been in business for 20 years, outsourcing for over eight years, and has been living in Manila (the heart of global outsourcing) since 2014. Derek is the founder and CEO of Outsource Accelerator, and is regarded as a leading expert on all things outsourcing.

“Excellent service for outsourcing advice and expertise for my business.”

Learn more
Banner Image
Get 3 Free Quotes Verified Outsourcing Suppliers
3,000 firms.Just 2 minutes to complete.
Learn more

Connect with over 3,000 outsourcing services providers.

Banner Image

Transform your business with skilled offshore talent.

  • 3,000 firms
  • Simple
  • Transparent
Banner Image